Methylome Analyses Implicate Fallopian TubeEpithelia as theOrigin forHigh-GradeSerous Ovarian Cancer
暂无分享,去创建一个
K. Odunsi | A. Karpf | D. Klinkebiel | Wa Zhang | S. Akers
[1] R. Ganapathi,et al. Biological role and clinical implications of homeobox genes in serous epithelial ovarian cancer. , 2016, Gynecologic oncology.
[2] Elvio G. Silva. The Origin of Epithelial Neoplasms of the Ovary: An Alternative View , 2016, Advances in anatomic pathology.
[3] V. Beral,et al. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.
[4] N. Barker,et al. Ovary and fimbrial stem cells: biology, niche and cancer origins , 2015, Nature Reviews Molecular Cell Biology.
[5] Zhaohui S. Qin,et al. Detection of differentially methylated regions from whole-genome bisulfite sequencing data without replicates , 2015, Nucleic acids research.
[6] Joshy George,et al. Whole–genome characterization of chemoresistant ovarian cancer , 2015, Nature.
[7] Matthew D. Schultz,et al. Human Body Epigenome Maps Reveal Noncanonical DNA Methylation Variation , 2015, Nature.
[8] D. Zack,et al. Characterization of tissue-specific differential DNA methylation suggests distinct modes of positive and negative gene expression regulation , 2015, BMC Genomics.
[9] Michael Q. Zhang,et al. Integrative analysis of 111 reference human epigenomes , 2015, Nature.
[10] D. Matei,et al. The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer , 2014, Clinical Cancer Research.
[11] Thomas Lengauer,et al. Comprehensive Analysis of DNA Methylation Data with RnBeads , 2014, Nature Methods.
[12] R. Mägi,et al. DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns , 2014, Genome Biology.
[13] K. Odunsi,et al. LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients. , 2014, Gynecologic oncology.
[14] Gregory A. Wyant,et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. , 2013, Cancer Cell.
[15] R. Drapkin,et al. Coming into focus: the nonovarian origins of ovarian cancer. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] A. Gnirke,et al. Charting a dynamic DNA methylation landscape of the human genome , 2013, Nature.
[17] Z. Dezső,et al. Gene Expression Analyses Support Fallopian Tube Epithelium as the Cell of Origin of Epithelial Ovarian Cancer , 2013, International journal of molecular sciences.
[18] D. Zack,et al. A novel methyl-binding domain protein enrichment method for identifying genome-wide tissue-specific DNA methylation from nanogram DNA samples , 2013, Epigenetics & Chromatin.
[19] W. Reik,et al. Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.
[20] Helene Myrtue Nielsen,et al. DNA methylation based biomarkers: practical considerations and applications. , 2012, Biochimie.
[21] Colm E. Nestor,et al. Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns , 2012, Genome Biology.
[22] Tuan V. Nguyen,et al. Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer. , 2012, Gynecologic oncology.
[23] Trupti Joshi,et al. Targeted bisulfite sequencing by solution hybrid selection and massively parallel sequencing , 2011, Nucleic acids research.
[24] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[25] H. Nagase,et al. Genome-wide survey reveals dynamic widespread tissue-specific changes in DNA methylation during development , 2011, BMC Genomics.
[26] Felix Krueger,et al. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications , 2011, Bioinform..
[27] V. Corces,et al. Enhancer function: new insights into the regulation of tissue-specific gene expression , 2011, Nature Reviews Genetics.
[28] K. Odunsi,et al. Coordinated Cancer Germline Antigen Promoter and Global DNA Hypomethylation in Ovarian Cancer: Association with the BORIS/CTCF Expression Ratio and Advanced Stage , 2011, Clinical Cancer Research.
[29] Ie-Ming Shih,et al. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory , 2010, The American journal of surgical pathology.
[30] Aaron R. Quinlan,et al. Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .
[31] Martin J. Aryee,et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts , 2009, Nature Genetics.
[32] R. Drapkin,et al. Ovarian Cancer Pathogenesis: A Model in Evolution , 2009, Journal of oncology.
[33] Rafael A. Irizarry,et al. Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.
[34] R. Drapkin,et al. Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer , 2007, Clinical Medicine & Research.
[35] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[36] E. Li,et al. DNA methylation regulates long-range gene silencing of an X-linked homeobox gene cluster in a lineage-specific manner. , 2006, Genes & development.
[37] Gordon B Mills,et al. Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon , 2005, Clinical Cancer Research.
[38] K. Robertson. DNA methylation and human disease , 2005, Nature Reviews Genetics.
[39] B. Vanderhyden,et al. Models of ovarian cancer—Are we there yet? , 2005, Molecular and Cellular Endocrinology.
[40] Jean-François Ethier,et al. Reproductive Biology and Endocrinology Open Access Animal Models of Ovarian Cancer , 2022 .
[41] P. V. van Diest,et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer , 2001, The Journal of pathology.
[42] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[43] S. Mok,et al. The biology of ovarian cancer. , 1998, Seminars in oncology.
[44] M F Fathalla,et al. Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.
[45] Neal P. Kawas,et al. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. , 2014, Human molecular genetics.
[46] P. Holland,et al. Evolution of homeobox genes , 2013, Wiley interdisciplinary reviews. Developmental biology.
[47] M. Widschwendter,et al. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. , 2011, Human reproduction update.
[48] K. Odunsi,et al. DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer. , 2007, Cancer immunity.
[49] W. Liang,et al. TM4 microarray software suite. , 2006, Methods in enzymology.